Neutropenia and antibiotics: when, what, how and why?
被引:0
|
作者:
Dickter, Jana
论文数: 0引用数: 0
h-index: 0
机构:
City Hope Natl Med Ctr, Div Infect Dis, Dept Med, Duarte, CA USACity Hope Natl Med Ctr, Div Infect Dis, Dept Med, Duarte, CA USA
Dickter, Jana
[1
]
Logan, Cathy
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Diego, Div Infect Dis & Global Hlth, La Jolla, CA USACity Hope Natl Med Ctr, Div Infect Dis, Dept Med, Duarte, CA USA
Logan, Cathy
[2
]
Taplitz, Randy
论文数: 0引用数: 0
h-index: 0
机构:
City Hope Natl Med Ctr, Div Infect Dis, Dept Med, Duarte, CA USA
City Hope Natl Med Ctr, Div Infect Dis, Dept Med, Duarte, CA 91010 USACity Hope Natl Med Ctr, Div Infect Dis, Dept Med, Duarte, CA USA
Taplitz, Randy
[1
,3
]
机构:
[1] City Hope Natl Med Ctr, Div Infect Dis, Dept Med, Duarte, CA USA
[2] Univ Calif San Diego, Div Infect Dis & Global Hlth, La Jolla, CA USA
[3] City Hope Natl Med Ctr, Div Infect Dis, Dept Med, Duarte, CA 91010 USA
Purpose of reviewOur aim is to review recent literature on antibiotic use in patients with neutropenia.Recent findingsProphylactic antibiotics are associated with risks and have limited mortality benefit. While early antibiotic use in febrile neutropenia (FN) is critical, early de-escalation or discontinuation may be safe in many patients.With an increasing understanding of potential risks and benefits of use and improved risk assessment, paradigms of antibiotic use in neutropenic patients are changing.
机构:
Budapest Univ Technol & Econ, Fac Mech Engn, MTA BME Res Grp Composite Sci & Technol, H-1111 Budapest, Hungary
Budapest Univ Technol & Econ, Fac Mech Engn, Dept Polymer Engn, H-1111 Budapest, HungaryBudapest Univ Technol & Econ, Fac Mech Engn, MTA BME Res Grp Composite Sci & Technol, H-1111 Budapest, Hungary
机构:
ST BONIFACE GEN HOSP,FAMILY PRACTICE UNIT,WINNIPEG R2H 2A6,MANITOBA,CANADAST BONIFACE GEN HOSP,FAMILY PRACTICE UNIT,WINNIPEG R2H 2A6,MANITOBA,CANADA